- April 20, 2015Lets Certify It
- April 20, 2015A New Paradigm For Industrial Hemp Farming on Tribal Lands
- April 16, 2015Farewell Entire Market Value Rule
- Spring 2015Apotex Inc. v. Daiichi Sankyo, Inc.
- Spring 2015Cadence Pharms., Inc. v. Exela PharmSci Inc.
- Summer 2015New ANDA Cases
- Spring 2015Acorda Therapeutics, Inc. v. Mylan Pharms. Inc.
- Spring 2015ANDA Litigation Settlements
- Spring 2015Ranbaxy Labs., Ltd. v. Burwell
- Spring 2015Generic Launches
- Spring 2015Takeda Pharm. Co., Ltd. v. TWi Pharms., Inc.
- Spring 2015Warner Chilcott Co., LLC v. Teva Pharms. USA, Inc.
- Spring 2015Forest Labs., Inc. v. Amneal Pharms. LLC
- Spring 2015Eli Lilly & Co. v. Mylan Pharms., Inc.
- Spring 2015Otsuka Pharm. Co., Ltd. v. Mylan Inc.
- Spring 2015Novartis Pharms. Corp. v. Mylan Inc.
- Spring 2015AstraZeneca LP v. Breath Ltd.
- Spring 2015Senju Pharm. Co., Ltd. v. Metrics, Inc.
- Spring 2015Teva Pharms USA, Inc. v. Sandoz, Inc.
- Spring 2015Spectrum Pharms., Inc. v. Sandoz Inc.
- Spring 2015New ANDA Cases
- Spring 2015Senju Pharm. Co., Ltd. v. Lupin Ltd.
- April 14, 2015Litigation Management for the In-House Generalist: Insurance, Indemnification and Litigation Holds
- April 13, 2015How Gelboim V BofA Affects Pending MDL Matters
- Spring 2015ANDA Approvals
- April, 2015You First: Manufacturing, IP, and the Coming 3D Printing Disruption
- March 31, 2015Companies Should Rethink Their European Patent Strategy
- March 31, 2015Litigation Management for the InHouse Generalist Receiving Complaints
- March 26, 2015Large-Packaged Goods and Robinson-Patman: Manufacturers Beware
- March 24, 2015SEPs Don't Need A Different Reasonable Royalty Analysis
- March 20, 2015Ex-U.S. Attorney to Fight for Indian Rights
- March 19, 2015Former US Attorney reflects on Indian cases
- March 18, 20153D Printing and Intellectual Property Law: Predictions for 2015
- March 17, 2015Litigation Management for the In-House Generalist: The Commencement Phase
- March 16, 2015Drafting a Better Nondisclosure Agreement
- March 16, 2015Eschew Obfuscation – Writing is for Communication
- March 13, 2015New Strategies for Venue in Hatch-Waxman Litigation
- March 11, 2015A New 'Footprint' Paradigm For Reasonable Royalty Damages
- March 2, 2015Legislature Bolsters Sales Rep Termination Act
- March 2015Patent Litigation, Chapter 12: Trial
- February 26, 2015Keeping Secrets in the Cloud: Are Storms Ahead For Trade Secret Protection?
- February 23, 2015Consumer Goods and Retail Roundtable
- February 20, 2015In the Interest of Justice
- A Modest Proposal to Disturb the Sound of Appellate Silence: Why the Eighth Circuit Should Articulate a Rule 23(f) Standard for Appeals of Class Certification Decisions
- February 12, 2015Taking the Pulse of Digital Health: Key Legal Issues Surrounding Wearable Technology
- Winter 2014Mylan Pharms., Inc. v. FDA
- Winter 2014Spectrum Pharms., Inc. v. Sandoz Inc.,
- Winter 2014Sandoz Inc. v. Amgen Inc.,
- Winter 2014Glenmark Generics Ltd. v. Ferring B.V.,
- Winter 2014The Medicines Co. v. Mylan Inc.
